CAL101
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Calluna Pharma AS
Overview
CAL101 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
CAL101 clinical trials
Explore related
Medical disclaimer. This page summarizes research about CAL101 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.